Clinical Trials Browser

Phase 1/2 × Radiopharmaceuticals × 90 days × Clear all

NCT07567521 2026-05-29

A Study of TRC003 in the Treatment of Patients With Progressive PSMA-positive mCRPC

Phase 1/2 Recruiting

Prostatic Neoplasms

NCT06059014 2026-04-24

PRadR

Phase 1/2 Completed

Clear-cell metastatic renal cell carcinoma